vTv Therapeutics (VTVT) Cash from Financing Activities: 2014-2025
Historic Cash from Financing Activities for vTv Therapeutics (VTVT) over the last 6 years, with Sep 2025 value amounting to $77.8 million.
- vTv Therapeutics' Cash from Financing Activities rose 3058.91% to $77.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $130.4 million, marking a year-over-year increase of 146.92%. This contributed to the annual value of $52.6 million for FY2024, which is 338.50% up from last year.
- According to the latest figures from Q3 2025, vTv Therapeutics' Cash from Financing Activities is $77.8 million, which was up 185,347.62% from -$42,000 recorded in Q2 2025.
- In the past 5 years, vTv Therapeutics' Cash from Financing Activities registered a high of $77.8 million during Q3 2025, and its lowest value of -$282,000 during Q4 2023.
- In the last 3 years, vTv Therapeutics' Cash from Financing Activities had a median value of $2.5 million in 2024 and averaged $20.3 million.
- Examining YoY changes over the last 5 years, vTv Therapeutics' Cash from Financing Activities showed a top increase of 4,711.72% in 2023 and a maximum decrease of 107.69% in 2023.
- Quarterly analysis of 5 years shows vTv Therapeutics' Cash from Financing Activities stood at $266,000 in 2021, then skyrocketed by 1,278.57% to $3.7 million in 2022, then plummeted by 107.69% to -$282,000 in 2023, then surged by 420.72% to $2.5 million in 2024, then soared by 3,058.91% to $77.8 million in 2025.
- Its Cash from Financing Activities was $77.8 million in Q3 2025, compared to -$42,000 in Q2 2025 and $2.5 million in Q3 2024.